PRTA FY 2012 Earnings — Prothena Corporation plc Revenue & Financial Results | Market Cap Arena

PRTAProthena Corporation plc

$516M

FY 2012 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$3M+424.3% YoY

Gross Profit

-$31M-1184.4% margin

Operating Income

-$41M-1557.9% margin

Net Income

-$41M-1558.0% margin

EPS (Diluted)

$-2.84

Cash Flow

Operating Cash Flow

-$42M

Free Cash Flow

-$43M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$129M

Total Liabilities

$3M

Stockholders' Equity

$126M

Cash & Equivalents

$125M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3M	$507,000	+424.3%
Gross Profit	-$31M	$507,000	-6309.3%
Operating Income	-$41M	-$29M	-41.6%
Net Income	-$41M	-$30M	-39.6%